Prognostic Role of a New Inflammatory Index with Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase (CII: Colon Inflammatory Index) in Patients with Metastatic Colorectal Cancer: Results from the Randomized Italian Trial in Advanced Colorectal Cancer (ITACa) Study [Corrigendum]

Casadei-Gardini A, Scarpi E, Ulivi P, et al. Cancer Manag Res. 2019;11:4357–4369.

The authors have advised that the affiliations are not correct in the published paper (page 4357). They have provided revised author and affiliations lists as follows, and confirm that the modifications do not alter their conflicts of interest status in regard to this work.

The authors confirm that the revised affiliation list reflects each of the author’s affiliations at the time of the study.

Andrea Casadei Gardini¹, Emanuela Scarpi², Paola Ulivi³, Maria Angela Palladino⁴, Caterina Accettura⁵, Ilaria Bernardini⁶, Andrea Spallanzani⁷, Fabio Gelsomino⁷, Jody Corbelli⁸, Giorgia Marisi³, Silvia Ruscelli¹, Martina Valgiusti¹, Giovanni Luca Frassineti¹, Alessandro Passardi¹

¹Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

²Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

³Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

⁴Medical Oncology Department, Piacenza Hospital, Piacenza, Italy.

⁵Medical Oncology Unit, Vito Fazzi Hospital, Lecce, Italy.

⁶Medical Oncology Unit, Ramazzini Hospital, Carpi, Italy.

⁷Department of Oncology and Hematology, Division of Oncology, University Hospital Modena, Modena, Italy.

⁸Oncology Unit, Degli Infermi Hospital, Faenza, Italy.